ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

SKYA vs LUNG // FORWARD P/E MULTIPLE

SkyAI Inc. (NASDAQ) VS. Pulmonx Corporation (NASDAQ) • 15-METRIC TALLY: SKYA 2 — LUNG 6
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SKYA VS. LUNG) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC SKYA LUNG SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin -30.00% 74.20% -104.20 LUNG /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -8.67% -24.15% +15.48 SKYA /fcf-yield <GO>
Operating Margin -60.00% -59.30% -0.70 LUNG /operating-margins <GO>
Net Profit Margin -60.00% -59.70% -0.30 LUNG /net-margins <GO>
Revenue Growth (YoY) — 8.00% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 11.30 0.20 +11.10 SKYA /balance-sheet <GO>
Piotroski F-Score Quality 2/9 6/9 -4.00 LUNG /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 74.0 79.1 -5.10 LUNG /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple ACTIVE — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $126.7M $135.9M -$9.2M LUNG /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR SKYA REV LUNG REV SKYA GROSS % LUNG GROSS % SKYA FCF LUNG FCF
FY 2025 $204.1K $90.5M -50.0% 74.2% -$11.0M -$32.8M
FY 2024 $0 $83.8M — 74.0% -$4.5M -$33.0M
FY 2023 $0 $68.7M — — -$8.5M -$37.6M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SKYA // BETA —
LUNG // BETA —